
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded nasal spray containing miconazole nitrate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing miconazole are listed in cream, ointment, suppository and tablet forms. It is also a component of FDA-approved kits.
This dose form is water-containing (aqueous). Under USP <795>, aqueous preparations carry shorter default beyond-use dates than nonaqueous ones, and a preservative in the base allows a longer date than no preservative. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Miconazole is an imidazole antifungal that compounding pharmacies prepare in topical creams, ointments, powders and oral rinses by prescription.
Miconazole is an imidazole antifungal. It blocks the fungal enzyme that makes ergosterol, a building block of the fungal cell membrane, and it also inhibits fungal peroxidases so that peroxide builds up inside the cell. Several manufactured products exist. Oravig, a buccal tablet placed on the gum, is FDA-approved for local treatment of oropharyngeal candidiasis in adults. Over-the-counter miconazole nitrate vaginal creams and suppositories (Monistat 1, 3 and 7) are approved for vaginal yeast infections, and over-the-counter creams, sprays and powders are sold for athlete's foot, jock itch and ringworm. A prescriber might order compounded miconazole for a strength or vehicle not manufactured, a combination with a corticosteroid or another antifungal in one preparation, an oral-rinse form, or a vehicle free of a specific allergen. Compounded preparations are not FDA-approved and require a prescription.
Miconazole products have no boxed warning. The Oravig label warns that allergic reactions including anaphylaxis have been reported with miconazole products; stop and get help right away for hives, swelling or trouble breathing. Do not use it if you are allergic to miconazole; the buccal tablet also contains milk protein. Warfarin is the key interaction: bleeding and bruising have been reported with topical, vaginal and oral miconazole, so INR needs close monitoring. Miconazole inhibits CYP2C9 and CYP3A4, so interactions with oral diabetes medicines, phenytoin and ergot drugs cannot be ruled out, although absorption from skin and mouth is small. The Oravig label says miconazole may cause fetal harm based on animal data; tell your prescriber if you are pregnant. LactMed considers it unlikely to affect a breastfed infant if excess is wiped off the nipples. If irritation is severe or persists, talk to your prescriber or pharmacist.
Miconazole inhibits fungal lanosterol 14-alpha-demethylase, depleting ergosterol, and additionally inhibits peroxidases, causing intracellular peroxide accumulation and cell death; the second mechanism is described as distinguishing it from other azoles, and yeasts remain largely susceptible after repeated exposure. Systemic absorption after topical, vaginal or buccal use is minimal; plasma levels after Oravig were mostly below quantification, salivary levels peaked at about 7 hours, and the terminal half-life after systemic administration is about 24 hours. It is hepatically metabolized with no active metabolites, less than 1% excreted unchanged in urine, and it inhibits CYP2C9 and CYP3A4. Labeled indications: Oravig buccal tablet for oropharyngeal candidiasis in adults; OTC miconazole nitrate vaginal products for vulvovaginal candidiasis; OTC topical products for tinea pedis, cruris and corporis. Prescribers have ordered compounded miconazole for nipple candidiasis in nursing mothers, where LactMed notes it is rarely chosen and offers no clear advantage over lanolin for sore nipples. Strength, vehicle and duration are per prescriber. Monitor INR in warfarin patients and watch for hypersensitivity, including in patients with prior azole reactions, since cross-reactivity data are lacking. Miconazole is not a controlled substance.
Wash your hands and blow your nose gently. Prime the pump if your label says to. Keep your head upright, close one nostril with a finger, insert the tip into the other nostril and breathe in slowly while pressing the pump the number of times on your label. Repeat in the other nostril if directed. Wipe the nozzle, recap, and wash your hands. Do not share the bottle.
Nasal sprays are aqueous. Under USP <795>, a preserved spray usually carries a beyond-use date of up to 35 days at room temperature or refrigerated, and an unpreserved one 14 days refrigerated. Follow the storage line on your label, keep out of reach of children, and discard after the beyond-use date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Inhale intranasally